
Región Metropolitana de Santiago
Este organismo compró $35.328.432.746 en 11.631 órdenes de compra , sobre todo en Medicamentos y productos farmacéuticos / Medicamentos anti infecciosos / Medicamentos antivirales y le compró principalmente a Sur Medical SpA.
237 meses con data · color por monto (sqrt scale)
| Año | Ene | Feb | Mar | Abr | May | Jun | Jul | Ago | Sep | Oct | Nov | Dic | Total año |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 |
| Proveedor | Monto | OCs |
|---|---|---|
| Sur Medical SpA 99.576.080-0 | $12.733.383.751 | 2 |
| Novartis Chile S.A. 83.002.400-k | $2.155.558.537 | 811 |
| Philips Chilena S.A. 90.761.000-4 | $1.578.097.602 | 2 |
| Siemens Sociedad Anonima 94.995.000-k | $805.699.625 | 4 |
| Glaxosmithkline Chile Farmaceutica Limitada 85.025.700-0 | $715.462.084 | 644 |
| Johnson y Johnson de Chile S.A. 93.745.000-1 | $691.297.413 | 150 |
| Asociacion de Dializados y Transplantados de Chile o Asodi 70.526.900-9 | $633.566.888 | 2.300 |
| Novofarma Service S.A. 96.945.670-2 | $623.410.279 | 203 |
| Pv Equip S.A. 79.895.670-1 | $595.049.257 | 21 |
| Gador Limitada 76.084.945-6 |
| $1366,4 M |
| 2025 | $2402,7 M |
| 2024 | $2107,2 M |
| 2023 | $2816,8 M |
| 2022 | $1338 M |
| 2021 | $1018,6 M |
| 2020 | $888,8 M |
| 2019 | $901,2 M |
| 2018 | $1471,2 M |
| 2017 | $786,1 M |
| 2016 | $14,2 mil M |
| 2015 | $919,8 M |
| 2014 | $428,8 M |
| 2013 | $340,8 M |
| 2012 | $359,5 M |
| 2011 | $701,4 M |
| 2010 | $913,7 M |
| 2009 | $590,7 M |
| 2008 | $571,8 M |
| 2007 | $1180,7 M |
| 2006 | $34,7 M |
237 períodos con data
Fuente: Agregaciones mensuales sobre OCs ingeridas
10 contrapartes
Fuente: Tabla top_contrapartes_comprador
| $580.637.383 |
| 300 |
| Código | Fecha | Proveedor | Estado | Monto |
|---|---|---|---|---|
| 2980-301-AG26 | 18-06-2026 | Johnson y Johnson de Chile S.A. | Aceptada | $1.547.000 |
| 2980-300-AG26 | 18-06-2026 | Novofarma Service S.A. | Aceptada | $415.103 |
| 2980-296-AG26 | 18-06-2026 | Glaxosmithkline Chile Farmaceutica Limitada | Aceptada | $544.217 |
| 2980-304-SE26 | 18-06-2026 | Fundacion Dr Jorge Perez Rifo | Aceptada | $36.781.681 |
| 2980-294-AG26 | 18-06-2026 | Intercontinental Group SpA | Aceptada | $1.499.400 |
| 2980-305-SE26 | 18-06-2026 | Fundacion Dr Jorge Perez Rifo | Aceptada | $13.412.065 |
| 2980-306-SE26 | 18-06-2026 | Fundacion Dr Jorge Perez Rifo | Aceptada | $4.769.074 |
| 2980-297-AG26 | 18-06-2026 | Johnson y Johnson de Chile S.A. | Aceptada |
| $2.623.950 |
| 2980-302-AG26 | 18-06-2026 | Glaxosmithkline Chile Farmaceutica Limitada | Aceptada | $738.347 |
| 2980-307-SE26 | 18-06-2026 | Fundacion Dr Jorge Perez Rifo | Aceptada | $1.664.810 |
| 2980-295-AG26 | 18-06-2026 | Laboratorios Biopas S.A. | Aceptada | $427.055 |
| 2980-299-AG26 | 18-06-2026 | Pfizer Chile S.A. | Aceptada | $146.370 |
| 2980-303-AG26 | 18-06-2026 | Laboratorios Andromaco S.A. | Aceptada | $5.255.040 |
| 2980-293-AG26 | 18-06-2026 | Mamey Group SpA | Aceptada | $199.920 |
| 2980-298-AG26 | 18-06-2026 | Glaxosmithkline Chile Farmaceutica Limitada | Aceptada | $352.240 |
| 2980-275-AG26 | 17-06-2026 | Johnson y Johnson de Chile S.A. | Aceptada | $6.669.902 |
| 2980-283-AG26 | 17-06-2026 | Pfizer Chile S.A. | Aceptada | $5.000.349 |
| 2980-277-AG26 | 17-06-2026 | Scienza Chile SpA | Aceptada | $5.414.500 |
| 2980-282-AG26 | 17-06-2026 | Novofarma Service S.A. | Aceptada | $4.760.095 |
| 2980-280-AG26 | 17-06-2026 | Astrazeneca S.A. | Aceptada | $5.634.679 |
| 2980-288-AG26 | 17-06-2026 | Johnson y Johnson de Chile S.A. | Aceptada | $6.669.902 |
| 2980-287-AG26 | 17-06-2026 | Distribuidora Qualimed Limitada | Enviada a proveedor | $1.872.559 |
| 2980-279-AG26 | 17-06-2026 | Novartis Chile S.A. | Aceptada | $2.697.646 |
| 2980-291-AG26 | 17-06-2026 | Distribuidora Qualimed Limitada | Enviada a proveedor | $1.752.156 |
| 2980-278-AG26 | 17-06-2026 | Novartis Chile S.A. | Aceptada | $2.697.646 |
| 2980-289-AG26 | 17-06-2026 | Productos Farmoquimicos Roche Limitada | Aceptada | $2.907.049 |
| 2980-292-TD26 | 17-06-2026 | Ecoclima SpA | Recepcion Conforme | $1.689.800 |
| 2980-281-AG26 | 17-06-2026 | Novartis Chile S.A. | Aceptada | $4.285.428 |
| 2980-285-AG26 | 17-06-2026 | Novartis Chile S.A. | Aceptada | $3.997.817 |
| 2980-276-AG26 | 17-06-2026 | Novofarma Service S.A. | Aceptada | $7.140.143 |